Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Silo Pharma (SILO) Operating Expenses (2019 - 2025)

Silo Pharma (SILO) has disclosed Operating Expenses for 7 consecutive years, with $783861.0 as the latest value for Q4 2025.

  • Quarterly Operating Expenses fell 57.16% to $783861.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.3 million through Dec 2025, down 9.71% year-over-year, with the annual reading at $4.3 million for FY2025, 9.71% down from the prior year.
  • Operating Expenses hit $783861.0 in Q4 2025 for Silo Pharma, down from $1.1 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $1.8 million in Q4 2024 to a low of $453415.0 in Q2 2021.
  • Historically, Operating Expenses has averaged $975340.4 across 5 years, with a median of $962351.0 in 2021.
  • Biggest five-year swings in Operating Expenses: skyrocketed 475.11% in 2021 and later plummeted 57.16% in 2025.
  • Year by year, Operating Expenses stood at $958982.0 in 2021, then surged by 74.51% to $1.7 million in 2022, then fell by 29.47% to $1.2 million in 2023, then soared by 55.04% to $1.8 million in 2024, then tumbled by 57.16% to $783861.0 in 2025.
  • Business Quant data shows Operating Expenses for SILO at $783861.0 in Q4 2025, $1.1 million in Q3 2025, and $1.3 million in Q2 2025.